Luis E. Raez/X
May 14, 2024, 16:10
Luis E. Raez: Unfortunatly adding IO to chemo/radiation is not working but we have other options
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post by Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, on X/Twitter, adding:
”Unfortunatly this approach of adding IO to chemo/radiation is not working but we have other options to explore and the most important thing we need good biomarkers to guide immunotherapy use.”
Quoting Patrick Forde’s post:
”Concurrent immunotherapy (+ chemotherapy) with standard radiation is not a viable approach in NSCLC, now a second negative phase 3 trial after pacific 2.”
Read further.
Source: Luis E. Raez/X and Patrick Forde/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54